Abstract

The feasibility of the sterile insect technique (SIT) as a malaria vector control strategy against Anopheles arabiensis has been under investigation over the past decade. One of the critical steps required for the application of this technique to mosquito control is the availability of an efficient and effective sex-separation system. Sex-separation systems eliminate female mosquitoes from the production line prior to irradiation and field release of sterile males. This is necessary because female mosquitoes can transmit pathogens such as malaria and, therefore, their release must be prevented. Sex separation also increases the efficiency of an SIT programme. Various sex-separation strategies have been explored including the exploitation of developmental and behavioural differences between male and female mosquitoes, and genetic approaches. Most of these are however species-specific and are not indicated for the major African malaria vectors such as An. arabiensis. As there is currently no reliable sex-separation method for An. arabiensis, various strategies were explored in an attempt to develop a robust system that can be applied on a mass-rearing scale. The progress and challenges faced during the development of a sexing system for future pilot and/or large-scale SIT release programmes against An. arabiensis are reviewed here. Three methods of sex separation were examined. The first is the use of pupal size for gender prediction. The second is the elimination of blood-feeding adult females through the addition of an endectocide to a blood meal source. The third is the establishment of a genetic sexing strain (GSS) carrying an insecticide resistance selectable marker (dieldrin-resistance rdl gene and/or other GABA receptor antagonists that can be used as alternative insecticides to dieldrin) or a temperature-sensitive lethal marker.

Highlights

  • Malaria is a major global health problem responsible for approximately 216 million cases and 445,000 deaths worldwide in 2016 alone [1]

  • High insemination rates (> 95%) were recorded, with no statistically significant difference found in comparison to virgin males and females that had not been previously exposed to ivermectin, suggesting that ivermectin treatment did not negatively impact male fitness. These results show that ivermectin can be used as a blood toxicant for sex separation, factors such as the inability to reliably guarantee complete elimination of females within a short period have to be addressed before this method can be applied on a mass-rearing scale

  • The success achieved in developing a genetic sexing strain (GSS) containing a South African genetic background and positive attributes such as accelerated development of aquatic stages and high survival rates at all life stages has provided encouragement for the application of this GSS in the local sterile insect technique (SIT) pilot studies, unless a suitable alternative to dieldrin-based sex-separation can be found

Read more

Summary

Introduction

Malaria is a major global health problem responsible for approximately 216 million cases and 445,000 deaths worldwide in 2016 alone [1]. Another concern observed during the South African ivermectin optimization trial was a high level of male mortality (21%) when spiked blood meals were presented serially to enhance female elimination.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call